Sopharma AD-Sofia (FRA:3JR) Cyclically Adjusted FCF per Share: €-0.37 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3JR Sopharma AD-Sofia FRA:3JR
57 GF Score
Price €2.19
GF Value €2.06
! 3 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Cyclically Adjusted FCF per Share?

Sopharma AD-Sofia FRA:3JR +3.79% 57 Cyclically Adjusted FCF per Share is €-0.37 as of Jun. 2026. GuruFocus rates FRA:3JR with a GF Score™ of 57/100 and a GF Value™ of €2.06. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sopharma AD-Sofia's adjusted free cash flow per share for the three months ended in Jun. 2026 was €0.005. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.37 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sopharma AD-Sofia was 1.00% per year. The lowest was -14.50% per year. And the median was -6.75% per year.

As of today (2026-09-01), Sopharma AD-Sofia's current stock price is €2.19. Sopharma AD-Sofia's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-0.37. Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF of today is .


Sopharma AD-Sofia  (FRA:3JR) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sopharma AD-Sofia Cyclically Adjusted FCF per Share Related Terms


Sopharma AD-Sofia Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Cyclically Adjusted FCF per Share Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -0.12 -0.10 -0.11 -0.28

Sopharma AD-Sofia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.29 -0.28 -0.39 -0.37

FRA:3JR vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF falls into.


FRA:3JR
57GF Score
Sopharma AD-Sofia FRA:3JR
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.005/333.9520*333.9520
=0.005

Current CPI (Jun. 2026) = 333.9520.

Sopharma AD-Sofia Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.078 241.018 -0.108
201609 -0.150 241.428 -0.207
201612 -0.052 241.432 -0.072
201703 -0.059 243.801 -0.081
201706 -0.163 244.955 -0.222
201709 -0.006 246.819 -0.008
201712 -0.093 246.524 -0.126
201803 -0.124 249.554 -0.166
201806 -0.228 251.989 -0.302
201809 -0.125 252.439 -0.165
201812 -0.137 251.233 -0.182
201903 -0.184 254.202 -0.242
201906 -0.195 256.143 -0.254
201909 -0.200 256.759 -0.260
201912 -0.105 256.974 -0.136
202006 0.000 257.797 0.000
202009 -0.170 260.280 -0.218
202012 -0.163 260.474 -0.209
202103 -0.097 264.877 -0.122
202106 -0.144 271.696 -0.177
202109 -0.116 274.310 -0.141
202112 -0.054 278.802 -0.065
202203 0.047 287.504 0.055
202206 0.028 296.311 0.032
202209 0.016 296.808 0.018
202212 0.242 296.797 0.272
202303 0.023 301.836 0.025
202306 -0.120 305.109 -0.131
202309 -0.258 307.789 -0.280
202312 0.302 306.746 0.329
202403 -0.644 312.332 -0.689
202406 0.377 314.175 0.401
202409 0.033 315.301 0.035
202412 -0.125 315.605 -0.132
202503 -0.127 319.799 -0.133
202506 -0.338 322.561 -0.350
202509 -0.006 324.800 -0.006
202512 0.035 324.054 0.036
202603 0.015 330.213 0.015
202606 0.005 333.952 0.005

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.37 mean?
Sopharma AD-Sofia (FRA:3JR) has a Cyclically Adjusted FCF per Share of €-0.37 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's Cyclically Adjusted FCF per Share too high?
Sopharma AD-Sofia's current Cyclically Adjusted FCF per Share is €-0.37. Overall, Sopharma AD-Sofia has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Cyclically Adjusted FCF per Share compare to MCK and COR?
Sopharma AD-Sofia's Cyclically Adjusted FCF per Share of €-0.37 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current Cyclically Adjusted FCF per Share is €-0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Sopharma AD-Sofia (FRA:3JR) has a current Cyclically Adjusted FCF per Share of €-0.37. The stock's GF Value™ is €2.06, compared to a current price of €2.19 — trading 6.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.37. Sopharma AD-Sofia's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sopharma AD-Sofia (FRA:3JR), the current Cyclically Adjusted FCF per Share is €-0.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be overvalued. The current stock price of €2.19 is trading 6.3% above its estimated GF Value™ of €2.06.

Key valuation signals for FRA:3JR:

  • Cyclically Adjusted FCF per Share: €-0.37
  • GF Value™: €2.06 vs. price of €2.19 (6.3% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges SPH:PolandSFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
57GF Score

Get the complete analysis for FRA:3JR

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.19
Price
€2.06
GF Value